Short answer
ORASURE TECHNOLOGIES INC (OSUR) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $31M (down 1.9% year over year) with net income of $6M.
Q2 2026 key financials · XBRL
- Revenue
- $31M
- −1.9% YoY · +9.7% QoQ
- Net income
- $6M
- +131.7% YoY · +127.9% QoQ
- Operating margin
- 17.8%
- Gross margin
- 43.5%
- EPS (diluted)
- $0.09
- +133.3% YoY · +128.1% QoQ
Source: XBRL data from the ORASURE TECHNOLOGIES INC (OSUR) Q2 2026 10-Q on SEC EDGAR. USD.
ORASURE TECHNOLOGIES INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $30.6M, down 2% YoY from $31.2M
- Gross margin 43.5% vs 42.1% YoY
- Diagnostics largest segment at $19.4M, up 1%; risk assessment lowest at $0 vs $0.4M
- Cash $160.6M vs $199.3M; operating cash use $23.8M and stock repurchases $7.0M
- Outlook: cash sufficient for next 12 months; CT/NG submission withdrawn, future resubmission planned
Risk Factors
- No material changes to 10-K risk factors for year ended December 31, 2025
- Regulatory and compliance risks carried forward unchanged from the March 9, 2026 Form 10-K
- Operational and competitive risks carried forward unchanged from the March 9, 2026 Form 10-K
- Financial, liquidity, debt, currency, and concentration risks carried forward unchanged from the March 9, 2026 Form 10-K
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORASURE TECHNOLOGIES INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.